REPLIMUNE GROUP, INC. Employee Count
The employee counts REPLIMUNE GROUP, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2026-03-31: Employees (as filed) 465; Filing 2026-06-29; Lease expense per employee $12,144.09.
- 2025-03-31: Employees (as filed) 479; Filing 2025-05-22; Lease expense per employee $11,847.60.
- 2024-03-31: Employees (as filed) 331; Filing 2024-05-16; Lease expense per employee $17,259.82.
- 2023-03-31: Employees (as filed) 284; Filing 2023-05-18; Lease expense per employee $19,869.72.
- Available history
- 2020-03-31 to 2026-03-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2026-03-31 | 465 full-time | 2026-06-29 | $12,144.09 total lease cost |
| 2025-03-31 | 479 full-time | 2025-05-22 | $11,847.60 total lease cost |
| 2024-03-31 | 331 full-time | 2024-05-16 | $17,259.82 total lease cost |
| 2023-03-31 | 284 full-time | 2023-05-18 | $19,869.72 total lease cost |
| 2022-03-31 | 206 full-time | 2022-05-19 | $27,446.60 total lease cost |
| 2021-03-31 | 152 full-time | 2021-05-20 | $36,960.53 total lease cost |
| 2020-03-31 | 122 full-time | 2020-06-03 | $27,409.84 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |